A Melanoma Vaccine for Metastatic Patients
Melanoma
A Melanoma Vaccine for Metastatic Patients
There’s only one vaccine that has been approved by the Food and Drug Administration for the treatment of metastatic melanoma patients. Talimogene Laherparepvec (T-VEC) is a modified herpes virus that’s injected directly into the melanoma lesion and causes the death of cancer cells. It is approved for melanoma that cannot be surgically removed. There have been a number of studies of other potential melanoma vaccines but so far none have been successful.
In addition to the vaccine, both targeted therapies and immunotherapy have been very successful in treating stage four disease.
Learn more about SurvivorNet's rigorous medical review process.
There’s only one vaccine that has been approved by the Food and Drug Administration for the treatment of metastatic melanoma patients. Talimogene Laherparepvec (T-VEC) is a modified herpes virus that’s injected directly into the melanoma lesion and causes the death of cancer cells. It is approved for melanoma that cannot be surgically removed. There have been a number of studies of other potential melanoma vaccines but so far none have been successful.
In addition to the vaccine, both targeted therapies and immunotherapy have been very successful in treating stage four disease.
Learn more about SurvivorNet's rigorous medical review process.
Immunotherapy for melanoma does often work well–but the side effects do need to be considered.
Later Stage Treatment: Immunotherapy for Melanoma
Immunotherapy for melanoma does often work well–but the side effects do need to be considered.